Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02612987
Other study ID # 2015/326
Secondary ID
Status Completed
Phase N/A
First received November 15, 2015
Last updated March 2, 2018
Start date October 2015
Est. completion date October 2017

Study information

Verified date March 2018
Source Uppsala University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Insomnia is a commonly reported comorbidity for adolescents with psychiatric conditions. It is well-known that insomnia can exacerbate the concurrent psychiatric symptom load. Treatment of insomnia has been extensively examined in adults, but studies with adolescents are sparse. The purpose of this pilot study is to assess the feasibility and efficacy of internet-based cognitive behavioral therapy for insomnia (iCBT) in outpatients of Children and Youth Psychiatry. Twenty-one adolescents will be recruited and receive 7 weeks of iCBT. Outcome will be measured at pre treatment, at post treatment and at a three months follow-up. Weekly assessments will also be made during treatment on primary outcome and a presumed process variable constructed for the purpose of this trial.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date October 2017
Est. primary completion date October 2017
Accepts healthy volunteers No
Gender All
Age group 13 Years to 18 Years
Eligibility Inclusion Criteria:

- To fulfill the diagnostic criteria for insomnia

- To have access to a computer with Internet connection

- No previous or ongoing CBT for insomnia

- No psychotropic medication or being on a stable dosage for at least six weeks before enrollment

Exclusion Criteria:

- Ongoing manic or psychotic episode

- Being at high risk of triggering manic or psychotic episode

- Ongoing sleep apnea

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Internet-based Cognitive Behaviour Therapy (iCBT)


Locations

Country Name City State
Sweden Uppsala University Hospital Uppsala Uppsala Län

Sponsors (3)

Lead Sponsor Collaborator
Uppsala University Hospital Karolinska Institutet, Uppsala University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Insomnia Severity Index (ISI; Morin, 1993) Given that this is an intervention study we are assessing changes in outcome over time. Pre treatment, weekly during treatment (e.g. from date of treatment start for seven weeks until treatment is terminated), post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up
Secondary The Core Consensus Sleep Diary (Core CSD; Carney et al., 2012) Given that this is an intervention study we are assessing changes in outcome over time. Pre treatment, weekly during treatment (e.g. from date of treatment start for seven weeks until treatment is terminated), post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up
Secondary Symptoms Checklist (SCL-90; Derogatis et al., 1994) Given that this is an intervention study we are assessing changes in outcome over time. Pre treatment, post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up
Secondary Montgomery-Åsberg Depression Rating Scale - Self report (MADRS-S; Svanborg & Åsberg, 1994) Given that this is an intervention study we are assessing changes in outcome over time. Pre treatment, post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up
See also
  Status Clinical Trial Phase
Withdrawn NCT02557880 - Sleep Application Diary and Sleep Hygiene in Adolescents N/A
Terminated NCT00750919 - Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007) Phase 3
Completed NCT00993850 - Sleep Disturbance and Bipolar Disorder Phase 3
Completed NCT00561821 - Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709) Phase 3
Completed NCT00631657 - A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia (21106/P05701/MK-8265-002) Phase 3
Active, not recruiting NCT00690196 - Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms N/A
Completed NCT00113906 - Melatonin Treatment After Laparoscopic Cholecystectomy Phase 2/Phase 3
Recruiting NCT04995263 - A Multicomponent Intervention for Prevention and Treatment of Sleep Disturbances in a Psychiatric Intensive Care Unit N/A
Completed NCT00561574 - A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001) Phase 3
Completed NCT01061242 - Intensive Care Unit (ICU) Sleep Quality and Neurocognitive Performance N/A
Recruiting NCT05565833 - Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND) Phase 2
Recruiting NCT04402619 - Online Cognitive Behavior Therapy for Comorbid Sleep Problems in Alcohol Use Disorder N/A
Completed NCT00000171 - Study of Melatonin: Sleep Problems in Alzheimer's Disease Phase 3